drugset
drugset / Trial / NCT04490031

Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)

NCT04490031 ↗

Phase 4 Recruiting 140 enrolled Universiti Kebangsaan Malaysia Medical Centre
RandomizedCrossoverDouble-blindHealth-services research

Summary

This is a study evaluating the usage of Ketamine as sedative agent in ERCP. The usage of Ketamine will be compared to the standard sedation in our center, which is Midazolam in combination with Pethidine as analgesia.

Timeline

Start
2020-03-01
Primary completion
2020-12-31
Completion
2021-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule — —

Indications

No indication recorded.